发明名称 |
Monoclonal Antibodies Against HER2 Epitope and Methods of Use Thereof |
摘要 |
This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications. |
申请公布号 |
US2017066830(A1) |
申请公布日期 |
2017.03.09 |
申请号 |
US201615344012 |
申请日期 |
2016.11.04 |
申请人 |
Mersana Therapeutics, Inc. |
发明人 |
Bodyak Natalya D.;DeVit Michael J.;Krauland Eric M.;Lowinger Timothy B.;Park Peter U.;Prinz Bianka;Yurkovetskiy Aleksandr V. |
分类号 |
C07K16/28;A61K38/08;A61K47/48;C07K16/32;C07K16/30 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated antibody or antigen binding fragment thereof that specifically binds to an epitope of the human HER2 receptor, wherein the antibody or antigen binding fragment thereof comprises a variable heavy chain complementarity determining region 1 (CDRH1) comprising the amino acid sequence FTFSSYSMN (SEQ ID NO: 25); a variable heavy chain complementarity determining region 2 (CDRH2) comprising the amino acid sequence YISSSSSTIYYADSVKG (SEQ ID NO: 26); a variable heavy chain complementarity determining region 3 (CDRH3) comprising the amino acid sequence GGHGYFDL (SEQ ID NO: 27); a variable light chain complementarity determining region 1 (CDRL1) comprising the amino acid sequence RASQSVSSSYLA (SEQ ID NO: 28); a variable light chain complementarity determining region 2 (CDRL2) comprising the amino acid sequence GASSRAT (SEQ ID NO: 21); and a variable light chain complementarity determining region 3 (CDRL3) comprising the amino acid sequence QQYHHSPLT (SEQ ID NO: 29). |
地址 |
Cambridge MA US |